Unknown

Dataset Information

Glycemic Control as an Early Prognostic Marker in Advanced Pancreatic Cancer.


ABSTRACT:

Purpose

Impaired glucose metabolism is present in most patients with pancreatic ductal adenocarcinoma (PDAC). Whereas previous studies have focused on pre-treatment glycemic indices and prognosis in those with concomitant diabetes, the effects of glycemic control during chemotherapy treatment on prognosis, in patients with and without diabetes, have not been well characterized. We examined the relationship between early glycemic control and overall survival (OS) in a cohort of patients with advanced PDAC treated in a community setting.

Patients and methods

Seventy-three patients with advanced PDAC (38% with diabetes) receiving chemotherapy while participating in a biobanking clinical trial were included. Clinical characteristics and laboratory results during 1 year were obta

SUBMITTER: Alpertunga I 

PROVIDER: S-EPMC7947820 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature